FBIO Fortress Biotech Inc

Fortress Biotech Inc is a biopharmaceutical company. The Company is engaged in the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.

$0.80
As of 07/01/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/19/2011
Outstanding shares:  107,413,121
Average volume:  841,363
Market cap:   $93,460,157
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BWT3FG4
Valuation   (See tab for details)
PE ratio:   -1.26
PB ratio:   0.91
PS ratio:   1.29
Return on equity:   -73.21%
Net income %:   -99.03%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy